These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19402265)

  • 1. Gradual filling up of TB drug pipeline: how can we play our role better?
    Kant L
    Indian J Tuberc; 2009 Jan; 56(1):1-4. PubMed ID: 19402265
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensified scale-up of public-private mix: a systems approach to tuberculosis care and control in India.
    Lal SS; Sahu S; Wares F; Lönnroth K; Chauhan LS; Uplekar M
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):97-104. PubMed ID: 21276304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children and multidrug-resistant tuberculosis in Mumbai (Bombay), India.
    Karande S; Bavdekar SB
    Emerg Infect Dis; 2002 Nov; 8(11):1360-1. PubMed ID: 12453371
    [No Abstract]   [Full Text] [Related]  

  • 5. Weight gain in patients with tuberculosis treated under directly observed treatment short-course (DOTS).
    Vasantha M; Gopi PG; Subramani R
    Indian J Tuberc; 2009 Jan; 56(1):5-9. PubMed ID: 19402266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric tuberculosis and DOTS strategy under RNTCP.
    Chugh S
    J Indian Med Assoc; 2008 Dec; 106(12):799-802. PubMed ID: 19370953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis 'retreatment others': profile and treatment outcomes in the state of Andhra Pradesh, India.
    Srinath S; Sharath B; Santosha K; Chadha SS; Roopa S; Chander K; Wares F; Chauhan LS; Wilson NC; Harries AD
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):105-9. PubMed ID: 21276305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis--challenges and opportunities.
    Jain RC
    Indian J Tuberc; 2011 Oct; 58(4):148-54. PubMed ID: 22533163
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors associated with declining numbers of chronic tuberculosis excretors in Japan.
    Hoshino H; Uchimura K; Kato S
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):169-73, i. PubMed ID: 21219676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century.
    Burman WJ
    Clin Infect Dis; 2010 May; 50 Suppl 3():S165-72. PubMed ID: 20397944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Science in India. Crowd-sourcing drug discovery.
    Bagla P
    Science; 2012 Feb; 335(6071):909. PubMed ID: 22362985
    [No Abstract]   [Full Text] [Related]  

  • 12. Status report on RNTCP.
    Chauhan LS
    Indian J Tuberc; 2009 Jan; 56(1):44-7. PubMed ID: 19402271
    [No Abstract]   [Full Text] [Related]  

  • 13. World Health Organization press release. WHO sees surge in progress against tuberculosis on eve of global summit.
    World Health Organization
    Saudi Med J; 2004 Aug; 25(8):1140-1. PubMed ID: 15457609
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current treatment of tuberculosis].
    García Ramos R; Lado Lado FL; Túnez Bastida V; Pérez del Molino Bernal ML; Cabarcos Ortiz de Barrón A
    An Med Interna; 2003 Feb; 20(2):91-100. PubMed ID: 12703164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative.
    Bhargava A; Jain Y
    Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicine. New TB drug promises shorter, simpler treatment.
    Cohen J
    Science; 2004 Dec; 306(5703):1872. PubMed ID: 15591168
    [No Abstract]   [Full Text] [Related]  

  • 17. Joining forces to develop weapons against TB: together we must.
    Freire M; Roscigno G
    Bull World Health Organ; 2002; 80(6):429. PubMed ID: 12131997
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness.
    Pantoja A; Lönnroth K; Lal SS; Chauhan LS; Uplekar M; Padma MR; Unnikrishnan KP; Rajesh J; Kumar P; Sahu S; Wares F; Floyd K
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):705-12. PubMed ID: 19460245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is this the time to revise the Revised National Tuberculosis Control Programme in India?--yes and no..
    Jindal SK; Agarwal R
    Natl Med J India; 2008; 21(4):159-62. PubMed ID: 19267034
    [No Abstract]   [Full Text] [Related]  

  • 20. Shifting the paradigm in tuberculosis control: illustrations from India.
    Ogden J; Rangan S; Uplekar M; Porter J; Brugha R; Zwi A; Nyheim D
    Int J Tuberc Lung Dis; 1999 Oct; 3(10):855-61. PubMed ID: 10524581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.